All Categories
History
Price (excluding tax)
Response Rate
100.0%
Response Time
88.9hours
Nucleofector™ kits and corresponding optimization protocols are available on a variety of Nucleofector™ platforms for optimal gene transfer into human coronary artery endothelial cells. The kit of choice for transfecting human coronary endothelial cells in the 4D-Nucleofector™, 96-well Shuttle™ and 384-well Nucleofector™ systems is the P5 Primary Cell Kit. Use in conjunction with the Mammalian Endothelial Cell Basic Protocol. The Nucleofector™II/2b device uses a human coronary artery endothelial cell-specific kit. ■Advantages ・Gene transfer efficiency: up to 57% ・Survival rate: up to 42% ■Applications ・Confirmed in Clonetics™ human coronary artery endothelial cells ・Ideal for cardiovascular research (e.g. thrombosis, atherosclerosis, hypertension)
You can search for other models from each index. The displayed value is the value of the currently selected part number.
See all 4 models in listPart Number
Nucleofector™ kit for human coronary artery endothelial cells (HCAEC)Handling Company
Lonza Co., Ltd.| Image | Price (excluding tax) |
|---|---|
|
|
Available upon quote |
Reviews shown here are reviews of companies.
Response Rate
100.0%
Response Time
88.9hrs
